Other fully vaccinated individuals do not need an additional vaccine dose right now.
Category Archives: COVID-19 News and Info
Governor Ducey Statement On Importance Of COVID-19 Vaccination
Governor Ducey: “Today, thanks to the miracle of modern science, we have something we didn’t have last year: a vaccine.”
TGen Looks Beyond COVID-19 as it Advances Pathogen Sequencing
Genomic analysis of SARS-CoV-2, aided by seqWell’s technology, increases sequencing output by 10-fold
Like priming a pump, changes in cells damaged by chronic lung disease can result in severe COVID
Results from a TGen-led international study suggest that SARS-CoV-2 takes advantage of genetic changes among patients with pre-existing lung diseasesContinue reading
PFIZER AND BIONTECH TO PROVIDE 500 MILLION DOSES OF COVID-19 VACCINE TO U.S. GOVERNMENT FOR DONATION TO POOREST NATIONS
- U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022
- Doses to be donated to approximately 100 low- and lower middle-income countries including those in the African Union via the COVAX Facility
- Effort is part of the companies’ recent pledge of two billion doses to ensure global equitable access to the vaccine
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
- In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years
- Data also submitted to European Medicines Agency (EMA) and other global regulators, with additional authorizations expected in coming weeks
Amid Humanitarian Crisis in India, Merck Announces Voluntary Licensing Agreements with Five Indian Generics Manufacturers to Accelerate and Expand Global Access to Molnupiravir, an Investigational Oral Therapeutic for the Treatment of COVID-19
Merck will also donate more than $5 million in supplies and equipment to aid relief efforts in IndiaContinue reading
GlobalMed Provides Support to Nonprofit Healthcare Organizations for $250M FCC COVID-19 Telehealth Funding
Eligible providers can source the virtual care technology solutions they need for application submission
Gilead Sciences Announces Steps to Expand Availability of Remdesivir in India
– Gilead Will Donate a Minimum of 450,000 Vials of Veklury® to the Government of India –
– Company Will Continue to Support Expansion of Local Production Capacity –
Johnson & Johnson Single-Shot COVID-19 Vaccine Phase 3 Data Published in New England Journal of Medicine
- Single-dose vaccine prevented hospitalization and death across all study participants, 28 days after vaccination
- Vaccine shown to be effective against severe/critical COVID-19 disease as early as seven days after vaccination, with efficacy continuing to increase eight weeks post-vaccination
- Vaccine also shown to be consistently effective against symptomatic infection, including in South Africa and Brazil where there was a high prevalence of rapidly emerging SARS-CoV-2 variants